CY1120107T1 - Κρυσταλλικο πολυμορφο των εκλεκτικων τροποποιητων ανδρογονου (r) ή (s)-ν-(4-κυανο-3-(τριφθορομεθυλ)φαινυλ)-3-(4-κυανοφαινοξυ)-2-υδροξυ-2-μεθυλοπροπαναμιδιου - Google Patents

Κρυσταλλικο πολυμορφο των εκλεκτικων τροποποιητων ανδρογονου (r) ή (s)-ν-(4-κυανο-3-(τριφθορομεθυλ)φαινυλ)-3-(4-κυανοφαινοξυ)-2-υδροξυ-2-μεθυλοπροπαναμιδιου

Info

Publication number
CY1120107T1
CY1120107T1 CY20181100359T CY181100359T CY1120107T1 CY 1120107 T1 CY1120107 T1 CY 1120107T1 CY 20181100359 T CY20181100359 T CY 20181100359T CY 181100359 T CY181100359 T CY 181100359T CY 1120107 T1 CY1120107 T1 CY 1120107T1
Authority
CY
Cyprus
Prior art keywords
trifthormethyl
kyyynyyph
kyan
finyl
modifiers
Prior art date
Application number
CY20181100359T
Other languages
English (en)
Inventor
Tai Ahn
James T. Dalton
Dave Dickason
David Hong
Thomas G. Bird
Original Assignee
Gtx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtx, Inc. filed Critical Gtx, Inc.
Publication of CY1120107T1 publication Critical patent/CY1120107T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά στερεές μορφές του (S)-N-(4-κυανο-3-(τριφθορομεθυλ)φαινυλ)-3-(4-κυανοφαινοξυ)-2-υδροξυ-2-μεθυλο-προπαν-αμιδίου και μέθοδο για την παραγωγή αυτών.
CY20181100359T 2007-09-11 2018-03-30 Κρυσταλλικο πολυμορφο των εκλεκτικων τροποποιητων ανδρογονου (r) ή (s)-ν-(4-κυανο-3-(τριφθορομεθυλ)φαινυλ)-3-(4-κυανοφαινοξυ)-2-υδροξυ-2-μεθυλοπροπαναμιδιου CY1120107T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96001207P 2007-09-11 2007-09-11
PCT/US2008/076066 WO2009036206A1 (en) 2007-09-11 2008-09-11 Solid forms of selective androgen receptor modulators

Publications (1)

Publication Number Publication Date
CY1120107T1 true CY1120107T1 (el) 2018-12-12

Family

ID=40452483

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100359T CY1120107T1 (el) 2007-09-11 2018-03-30 Κρυσταλλικο πολυμορφο των εκλεκτικων τροποποιητων ανδρογονου (r) ή (s)-ν-(4-κυανο-3-(τριφθορομεθυλ)φαινυλ)-3-(4-κυανοφαινοξυ)-2-υδροξυ-2-μεθυλοπροπαναμιδιου

Country Status (20)

Country Link
US (1) US7977386B2 (el)
EP (2) EP2871177B1 (el)
JP (3) JP5452492B2 (el)
KR (3) KR101580905B1 (el)
CN (3) CN101855198B (el)
AU (1) AU2008298901C1 (el)
CA (3) CA2709118C (el)
CY (1) CY1120107T1 (el)
DK (1) DK2205552T3 (el)
EA (1) EA018611B1 (el)
ES (1) ES2665007T3 (el)
HR (1) HRP20180500T1 (el)
HU (1) HUE036762T2 (el)
IL (2) IL204352A (el)
LT (1) LT2205552T (el)
MX (6) MX2010002784A (el)
NO (1) NO2205552T3 (el)
PL (1) PL2205552T3 (el)
PT (1) PT2205552T (el)
WO (1) WO2009036206A1 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
JP5452492B2 (ja) * 2007-09-11 2014-03-26 ジーティーエックス・インコーポレイテッド 選択的アンドロゲン受容体調節因子の固体形態
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EP2523556A4 (en) * 2010-01-11 2013-08-28 Gtx Inc METHOD FOR TREATING MIBROMED DYNAMIC FUNCTION
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
RU2717835C2 (ru) 2012-07-13 2020-03-26 Джи Ти Икс, ИНК. Способ лечения андроген-рецептор(ar)-положительных форм рака молочной железы с использованием селективных модуляторов андрогенных рецепторов (sarm)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN110563607B (zh) * 2019-10-25 2022-07-08 许昌远志生物科技有限公司 一种mk-2866的精制方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038110A1 (en) 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US7855229B2 (en) 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
DE60124322T2 (de) * 2000-08-24 2007-05-31 University Of Tennessee Research Foundation, Knoxville Selektive modulatoren des androgenrezeptors und methoden zu deren verwendung
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
IL155041A0 (en) * 2000-09-21 2003-10-31 Bristol Myers Squibb Co Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds
DK1463497T3 (da) * 2001-12-06 2012-01-30 Gtx Inc Behandling af muskelsvind med selektive androgenreceptormodulatorer
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US7705182B2 (en) * 2002-02-28 2010-04-27 University Of Tennessee Research Foundation Multi-substituted selective androgen receptor modulators and methods of use thereof
CA2502209A1 (en) * 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
US7968721B2 (en) * 2003-01-13 2011-06-28 University Of Tennessee Research Foundation Large-scale synthesis of selective androgen receptor modulators
EP2476415A3 (en) 2003-10-14 2012-08-29 University of Tennessee Research Foundation Treating bone-related disorders with selective androgen receptor modulators
EP1931199A4 (en) 2005-08-31 2009-07-29 Univ Tennessee Res Foundation TREATMENT OF RENAL DISEASE, BURNS, INJURIES OR SPINAL CORD INJURY USING ANDROGEN RECEPTOR SELECTIVE MODULATORS
TW200730505A (en) 2005-12-07 2007-08-16 Merck & Co Inc Polymorphs of an androgen receptor modulator
CN1825959A (zh) * 2006-03-02 2006-08-30 复旦大学 一种基于自适应多步搜索的图像跟踪算法
JP5452492B2 (ja) * 2007-09-11 2014-03-26 ジーティーエックス・インコーポレイテッド 選択的アンドロゲン受容体調節因子の固体形態
US7968603B2 (en) * 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators

Also Published As

Publication number Publication date
US20090088480A1 (en) 2009-04-02
EP2205552A1 (en) 2010-07-14
JP2014133744A (ja) 2014-07-24
EA201070350A1 (ru) 2010-12-30
MX2018014065A (es) 2020-09-02
PL2205552T3 (pl) 2018-07-31
NO2205552T3 (el) 2018-07-28
US7977386B2 (en) 2011-07-12
CA2709118C (en) 2018-03-13
AU2008298901B2 (en) 2013-05-09
HRP20180500T1 (hr) 2018-06-01
KR101691877B1 (ko) 2017-01-02
WO2009036206A1 (en) 2009-03-19
CN101855198B (zh) 2013-07-10
CA2709118A1 (en) 2009-03-19
EP2871177A1 (en) 2015-05-13
KR20170001736A (ko) 2017-01-04
MX336760B (es) 2016-01-29
JP5599380B2 (ja) 2014-10-01
EP2205552B1 (en) 2018-02-28
CN101855198A (zh) 2010-10-06
EA018611B1 (ru) 2013-09-30
EP2871177B1 (en) 2019-07-17
PT2205552T (pt) 2018-04-24
MX341090B (es) 2016-08-08
KR20160003335A (ko) 2016-01-08
KR20100090239A (ko) 2010-08-13
IL251483A0 (en) 2017-05-29
IL204352A (en) 2013-10-31
JP5727636B2 (ja) 2015-06-03
CA2886498C (en) 2017-09-26
CN103073450A (zh) 2013-05-01
JP2010539181A (ja) 2010-12-16
DK2205552T3 (en) 2018-04-16
MX351941B (es) 2017-11-03
MX2010002784A (es) 2011-06-01
HUE036762T2 (hu) 2018-07-30
AU2008298901A1 (en) 2009-03-19
LT2205552T (lt) 2018-04-10
CA2886501A1 (en) 2009-03-19
CA2886498A1 (en) 2009-03-19
JP5452492B2 (ja) 2014-03-26
CN103553966A (zh) 2014-02-05
ES2665007T3 (es) 2018-04-24
JP2012067118A (ja) 2012-04-05
CN103553966B (zh) 2016-09-07
CA2886501C (en) 2018-03-27
CN103073450B (zh) 2014-12-03
AU2008298901C1 (en) 2013-10-03
KR101580905B1 (ko) 2015-12-29
EP2205552A4 (en) 2012-04-18
MX360801B (es) 2018-11-16

Similar Documents

Publication Publication Date Title
CY1120107T1 (el) Κρυσταλλικο πολυμορφο των εκλεκτικων τροποποιητων ανδρογονου (r) ή (s)-ν-(4-κυανο-3-(τριφθορομεθυλ)φαινυλ)-3-(4-κυανοφαινοξυ)-2-υδροξυ-2-μεθυλοπροπαναμιδιου
CY1112754T1 (el) Μεθοδοι και ενδιαμεσα για την παρασκευη παραγωγων ν4-φαινυλ-κιναζολιν-4-αμινης
DK2046726T3 (da) Fremstilling af (2R,3R)-3-3-methoxyphenyl)-N,N, 2-trimethylpentanamin
EA201200741A1 (ru) Способ получения этексилата дабигатрана
EA201000396A1 (ru) Новые фунгициды
IL187056A0 (en) Synthesis of bis (thio-hydrazide amide) salts
EA201070428A1 (ru) Ингибиторы hdac
DE602006018156D1 (de) Verfahren zur synthese von 5-(methyl-1h-imidazol-1-yl)-3-(trifluormethyl)benzolamin
LTC1912640I2 (lt) HDAC inhibitoriaus panobinostato panaudojimas mielomos gydymui
DK1954690T3 (da) Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
ATE443991T1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
DE602006017369D1 (de) Verfahren zur synthese von 5-(methyl-1h-imidazol-1-yl)-3-(trifluormethyl)-benzeneamin
EA200870038A1 (ru) Способ получения аминов
ATE465152T1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
CO6390054A2 (es) Formas cristalinas de un compuesto 3-carboxipropil-aminotetralina
NO20090896L (no) Farmakokinetisk forbedrede forbindelser
CY1118305T1 (el) Πολυμορφικη μορφη της ν-[4-(τριφθορομεθυλο)βενζυλο]-4-μεθοξυβουτυραμιδης
CY1114798T1 (el) Ενωσεις σουλφοναμιδιου για τη θεραπευτικη αντιμετωπιση αναπνευστικων διαταραχων
EA200970116A1 (ru) Кристаллический гидрохлорид неморубицина
ZA200805701B (en) Salts of styphnic acid
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
DE502006004812D1 (de) Fungizide 6-phenyl-pyrazolopyrimidin-7-ylamine
ECSP099599A (es) Procedimientos para la preparación de compuestos de urea sustituidos con piperidinilo
SE0402485D0 (sv) Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt